Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12310996
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 12310988
BCMA chimeric antigen receptors and uses thereof
granted -
US 12310934
Methods of treatment of spontaneous preterm birth
granted -
US 12310943
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12310968
Chiral diaryl macrocycles and uses thereof
granted -
US 12310956
Topical roflumilast formulation having improved delivery and plasma half-life
granted -
US 12310954
Salivary gland regeneration
granted -
US 12311026
Therapeutic uses for sodium thiosulfate formulations
granted -
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12310965
Treatment of cancer utilizing an identified adenosine fingerprint
granted -
US 12310997
Compositions and methods of treating ocular diseases
granted -
US 12311059
Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
granted -
US 12313635
Biomarker for thoracic aortic aneurysm
granted -
US 12312616
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 12312357
PRMT5 inhibiting compounds and uses thereof
granted -
US 12312589
RNA-nanostructured double robots and methods of use thereof
granted -
US 12312377
Biconjugatable labels and methods of use
granted -
US 12310986
Compositions and methods for the treatment of cancer cells by induction of cytotoxic oxidative stress
granted -
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12312375
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
granted -
US 12311054
Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease
granted -
US 12312345
Fluoroalkyl-oxadiazoles and uses thereof
granted -
US 12310944
Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.